Psychedelics Colorado votes to decriminalize use and possession of natural psychedelics It also introduces state-regulated 'healing centers' where trained facilitators can offer psychedelic-assisted sessions Natalia Buendia CalvilloDecember 29, 2022
Psychedelics Non-profit launches supporting psychedelic traditions of Mexico’s Indigenous peoples Quetzalli will be collaborating with the Mexican charities Ha Ta Tukari and Reserva Natural Rancho Los Ocotes Rowan DunneDecember 22, 2022
Psychedelics Quebec becomes first province to pay doctors for psilocybin-assisted therapy Two physicians were paid by the provincial government for facilitating the therapy earlier this year Rowan DunneDecember 15, 2022
Psychedelics Awakn set to research ketamine for alcohol use disorder The trial will be held at 7 NHS sites in the U.K. with the NIHR funding 66% of the cost Rowan DunneDecember 14, 2022
Canada Health Canada provides guidance for clinical trials on psychedelics The notice to stakeholders outlined risk management and consent expectations for the study of psychoactive drugs Rowan DunneDecember 5, 2022
Cannabis Field Trip offers free psychedelic-assisted therapy for laid off tech workers The program combines ketamine therapy, medical and therapeutic guidance, wellness classes, and week-by-week holistic programming Natalia Buendia CalvilloNovember 30, 2022
Canada Psilocybin advocates protest in Ottawa demanding fair medical access The cohort led by TheraPsil will be meeting with parliament members and protesting outside the Centre Block Rowan DunneNovember 28, 2022
Business The Good Shroom Co reports 600% year-over-year revenue growth Revenue mushrooming was attributed to the company's cannabis operations and functional fungi drinks Rowan DunneNovember 24, 2022
Cannabis U.S. senators introduce bill to improve access to psilocybin and MDMA The bill would reduce 'unreasonably burdensome rules and regulations' Rowan DunneNovember 23, 2022
Canada Filament Health to supply psilocybin for federally-funded psychedelics clinical trial The trial is the first psilocybin study funded by the Canadian Institutes of Health Research (CIHR) Natalia Buendia CalvilloNovember 17, 2022